|
⚲
|
| Keyboard |
| David Catala | |
|---|---|
| Firm | Pharmakon Advisors LP |
| Address | Avantor Performance Materials Holdings 5, Rue Du Kiem Luxembourg, N4 L-1857 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pharmakon Advisors LP | |||||
| Biopharma Secured Investments III SARL | 021-199818 | Executive Officer | 247.8 M of 247.8 M |
344.9 M | |
| Biopharma Secured Investments II SARL | 021-157021 | Executive Officer | 184.1 M | 138.5 M | |
| Avantor Performance Materials Holdings Sa | 021-184828 | Director | 0.8 M of 0.8 M |
||
| Biopharma Secured Debt Fund II S AR L | 021-157019 | Executive Officer | 184.1 M | ||
| Avantor Performance Materials Holdings Sa | 021-150746 | Director | 90.6 M | ||